CSL Limited

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CSL Limited and other ETFs, options, and stocks.

About CSLLY

CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. It operates through the following segments: CSL Behring, CSL Seqirus, and CSL Vifor. 

CEO
Gordon Naylor
CEOGordon Naylor
Employees
29,000
Employees29,000
Headquarters
Melbourne, Victoria (VIC)
HeadquartersMelbourne, Victoria (VIC)
Founded
1961
Founded1961
Employees
29,000
Employees29,000

CSLLY Key Statistics

Market cap
51.43B
Market cap51.43B
Price-Earnings ratio
36.70
Price-Earnings ratio36.70
Dividend yield
2.57%
Dividend yield2.57%
Average volume
197.28K
Average volume197.28K
High today
$53.80
High today$53.80
Low today
$52.95
Low today$52.95
Open price
$53.10
Open price$53.10
Volume
15.10K
Volume15.10K
52 Week high
$89.71
52 Week high$89.71
52 Week low
$52.00
52 Week low$52.00

CSLLY News

TipRanks 17h
CSL Earnings Call: Resilient Core Amid Heavy Impairments

Csl Ltd ((CSLLY)) has held its Q2 earnings call. Read on for the main highlights of the call. Valentine's Day Sale - 70% Off Unlock hedge fund-level data and po...

TipRanks 4d
CSL downgraded to Sector Perform from Outperform at RBC Capital

RBC Capital downgraded CSL (CMXHF) to Sector Perform from Outperform with a price target of A$176, down from A$230. The company’s first-half results missed cons...

TipRanks 5d
CSL Discloses Final Director Interest Notice as Paul McKenzie Steps Down

CSL ( (AU:CSL) ) has provided an update. CSL Limited has announced that Paul McKenzie ceased to be a director of the company on 10 February 2026, with this not...

More CSLLY News

CNBC 5d
Shares of Australian biotech major CSL plunge to 8-year low after CEO departure, weak earnings

Shares of Australian biotech firm CSL plunged to an 8-year low Wednesday after it announced the exit of Paul McKenzie as chief executive officer, and posted wea...

Shares of Australian biotech major CSL plunge to 8-year low after CEO departure, weak earnings
TipRanks 6d
CSL names veteran executive Gordon Naylor interim CEO as Paul McKenzie retires

The latest update is out from CSL ( (AU:CSL) ). CSL has announced the retirement of Chief Executive Officer and Managing Director Paul McKenzie, with long‑time...

Bloomberg 6d
CSL Says CEO Paul McKenzie Is Stepping Down Immediately

CSL Ltd. said Chief Executive Officer Paul McKenzie is stepping down, effective immediately, a day before the company reports earnings. Former senior executive...

CSL Says CEO Paul McKenzie Is Stepping Down Immediately

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.